AeroLeads people directory · profile

Louis Vuga, Md., Mph, Phd. Email & Phone Number

Program Director at National Heart Lung and Blood Institute National Institutes of Health
Location: Bethesda, Maryland, United States 6 work roles 3 schools
LinkedIn matched
✓ Verified August 2026 3 data sources Profile completeness 100%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
National Heart Lung and Blood Institute National Institutes of Health
Role
Program Director
Location
Bethesda, Maryland, United States

Who is Louis Vuga, Md., Mph, Phd.? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Louis Vuga, Md., Mph, Phd. is listed as Program Director at National Heart Lung and Blood Institute National Institutes of Health, based in Bethesda, Maryland, United States. AeroLeads shows a matched LinkedIn profile for Louis Vuga, Md., Mph, Phd..

Louis Vuga, Md., Mph, Phd. previously worked as Program Director at National Heart, Lung, And Blood Institute (Nhlbi) National Institutes Of Health (Nih) and Assistant Professor of Medicine at University of Pittsburgh at University Of Pittsburgh School Of Medicine. Louis Vuga, Md., Mph, Phd. holds Doctor Of Philosophy (Ph.D.), Clinical & Translational Science from Clinical Translational Science Institute, University Of Pittsburgh..

Profile bio

About Louis Vuga, Md., Mph, Phd.

As January 2017, I am a Program Director for Pulmonary Fibrosis, Sarcoidosis, and other rare lung diseases at NHLBI. I oversee several clinical research protocols for phase I, Phase II and Phase III trials. Work with DSMB, DCC and CCC investigators and evaluate their reports as well as resolve complex problems of clinical trials or observational studies. I implement essential partnership with patients’ foundations and scientists in the field of rare lung diseases to facilitate clinical and human subjects’ research. Additionally, I authored several funding initiatives for Heart, Blood and sleep disorders (HLBS) research as well as COVID 19 research. Since June 2020, I serve as a Project Manager for the NIH’s Rapid Acceleration of Diagnostics (RADx) Tech initiative, a dedicated Congressional appropriation to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing. My expertise in study design and analysis, and validation of emerging technologies enabled me to be incorporated into RADx Tech team and I provided critical management for about $ 50 Million contract projects in fight against COVID-19. I earnt two NIH Director’s (Dr. Francis Collins) awards in 2021 and received HHS Secretary’s (Mr. Xavier Becerra) award for distinguished services in May 2022. I obtained MD degree at Karl Franzens University, Graz, Austria and had extensive clinical work experience at University Hospital in Graz, where I did my medical residency. Later I successfully obtained Educational Commission for Foreign Medical Graduates (ECFMG) certification in United States and obtained training in pulmonary medicine at UPMC as observer fellow. Further, I achieved multi-disciplinary MPH and PhD degree in clinical and transitional sciences at University of Pittsburgh and accomplished postdoctoral fellowship at Simmons’s center for interstitial lung diseases at UPMC under the mentorship of Professor Dr. Naftali Kaminski. As an NIH funded investigator with expertise in genomic and proteomic of chronic lung diseases, I was employed as an assistant professor of medicine at Division of Pulmonary, Allergy, and Critical Care Medicine. I am expert in genomic, proteomic of chronic lung diseases, wide-ranging proficiency in clinical, biomedical, epidemiological, statistical methods, and translational sciences. Contributions to Science are found in the complete list of published works in the link.http://www.ncbi.nlm.nih.gov/pubmed/term=Vuga%20LJ%5BAuthor%5D&cauthor=true&cauthor_uid=24628285

Listed skills include Clinical Research, Genomics, Biomarkers, Cell Biology, and 21 others.

Current workplace

Louis Vuga, Md., Mph, Phd.'s current company

Company context helps verify the profile and gives searchers a useful next step.

National Heart Lung and Blood Institute National Institutes of Health
National Heart Lung And Blood Institute National Institutes Of Health
Program Director
Bethesda, MD, US
6 roles

Louis Vuga, Md., Mph, Phd. work experience

A career timeline built from the work history available for this profile.

Program Director

National Heart Lung And Blood Institute National Institutes Of Health

Bethesda, Md, Us

Program Director

National Heart, Lung, And Blood Institute (Nhlbi) National Institutes Of Health (Nih)

Assistant Professor Of Medicine At University Of Pittsburgh

Pittsburgh, Pa, Us

Publications[1] Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N: WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol.2009, 41:583-9.[2] Gilani SR, Vuga LJ, Lindell KO, Gibson KF, Xue J, Kaminski N, Valentine VG, Lindsay EK, George MP, Steele C, Duncan SR: CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PloS One 2010, 5:e8959[3] Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF: Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012, 185:67-76.[4] Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, McMillan M, Kahn M, Kaminski N: Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012, 47:879-87.[5] Vuga LJ, Milosevic J, Pandit K, Ben-Yehudah A, Chu Y, Richards T, Sciurba J, Myerburg M, Zhang Y, Parwani AV, Gibson KF, Kaminski N: Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis. PLoS ONE 8(12): PMCID: PMC3869779.[6] Vuga LJ , Tedrow JR, Pandit KV, Kass JD, Xue J, Leader JK, Gibson KF, Kaminski N, Sciurba FC, Duncan SR: C-X-C Motif Chemokine 13 (CXCL13) is a prognostic biomarker of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC, PMID:24628285.[7] Agassandian M, Tedrow JR, Sembrat J, Kass DJ, Zhang Y, Goncharova EA, Kaminski N, Mallampalli RK, Vuga LJ. VCAM-1 is a TGF-β inducible gene upregulated in idipathic plmnary fibrosis. Cell Signal 2015 Sep 18; 27 (12) 24467-73. PMID 26386411

Sep 2011 - Jun 2016

Resident

Lkh-Universitaetsklinikum / Lkh-Leoben, Austria
Jan 2000 - Mar 2002
3 education records

Louis Vuga, Md., Mph, Phd. education

Doctor Of Philosophy (Ph.D.), Clinical & Translational Science

Clinical Translational Science Institute, University Of Pittsburgh.

Master Of Public Health (M.P.H.), Multi/Interdisciplinary Studies

Graduate School Of Public Health, University Of Pittsburgh

Doctor Of Medicine (M.D.), Medicine

Karls Franzens University, Graz, Austria
FAQ

Frequently asked questions about Louis Vuga, Md., Mph, Phd.

Quick answers generated from the profile data available on this page.

What company does Louis Vuga, Md., Mph, Phd. work for?

Louis Vuga, Md., Mph, Phd. works for National Heart Lung and Blood Institute National Institutes of Health.

What is Louis Vuga, Md., Mph, Phd.'s role at National Heart Lung and Blood Institute National Institutes of Health?

Louis Vuga, Md., Mph, Phd. is listed as Program Director at National Heart Lung and Blood Institute National Institutes of Health.

Where is Louis Vuga, Md., Mph, Phd. based?

Louis Vuga, Md., Mph, Phd. is based in Bethesda, Maryland, United States while working with National Heart Lung and Blood Institute National Institutes of Health.

What companies has Louis Vuga, Md., Mph, Phd. worked for?

Louis Vuga, Md., Mph, Phd. has worked for National Heart Lung And Blood Institute National Institutes Of Health, National Heart, Lung, And Blood Institute (Nhlbi) National Institutes Of Health (Nih), University Of Pittsburgh School Of Medicine, and Lkh-Universitaetsklinikum / Lkh-Leoben, Austria.

How can I contact Louis Vuga, Md., Mph, Phd.?

You can use AeroLeads to view verified contact signals for Louis Vuga, Md., Mph, Phd. at National Heart Lung and Blood Institute National Institutes of Health, including work email, phone, and LinkedIn data when available.

What schools did Louis Vuga, Md., Mph, Phd. attend?

Louis Vuga, Md., Mph, Phd. holds Doctor Of Philosophy (Ph.D.), Clinical & Translational Science from Clinical Translational Science Institute, University Of Pittsburgh..

What skills is Louis Vuga, Md., Mph, Phd. known for?

Louis Vuga, Md., Mph, Phd. is listed with skills including Clinical Research, Genomics, Biomarkers, Cell Biology, Science, Biomarker Discovery, Molecular Biology, and Cell Culture.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.